Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring 02/10/2023 OBSERVATIONAL unchanged 1,293.85 0 With Love, Grandma ("Con Cariño, Abuelita") Pilot Study 02/10/2023 INTERVENTIONAL unchanged 1,293.85 0 Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream 02/10/2023 INTERVENTIONAL unchanged 1,293.85 0 LLLT for BCRL: a Randomized, Placebo-controlled Study 02/13/2023 INTERVENTIONAL unchanged 1,290.85 0 Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages 02/13/2023 INTERVENTIONAL unchanged 1,290.85 0 Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor 02/13/2023 INTERVENTIONAL unchanged 1,290.85 0 Physical Activity Intervention for Black Women With Asthma 02/14/2023 INTERVENTIONAL unchanged 1,289.85 0 Cohort of Twin Pregnancy and the Offspring 02/14/2023 OBSERVATIONAL unchanged 1,289.85 0 Screening Triage and Risk Stratification 02/14/2023 OBSERVATIONAL unchanged 1,289.85 0 Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index 02/15/2023 INTERVENTIONAL unchanged 1,288.85 0 Impact of Time on Sexual Function (FSFI® Score) After Hysterectomy 02/15/2023 INTERVENTIONAL unchanged 1,288.85 0 Effectiveness of Educational Intervention on Sustainable Breastfeeding: The GREEN MOTHER Project 02/15/2023 INTERVENTIONAL unchanged 1,288.85 0 Effects of the Contraceptive Implant in Women With Sickle Cell Disease 02/15/2023 INTERVENTIONAL unchanged 1,288.85 0 18F-FDG PET/CT Imaging for Breast Cancer 02/16/2023 INTERVENTIONAL unchanged 1,287.85 0 Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients 02/16/2023 OBSERVATIONAL unchanged 1,287.85 0 Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen 02/16/2023 OBSERVATIONAL unchanged 1,287.85 0 Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery 02/16/2023 INTERVENTIONAL unchanged 1,287.85 0 Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening 02/16/2023 INTERVENTIONAL unchanged 1,287.85 0 Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase 02/16/2023 INTERVENTIONAL unchanged 1,287.85 0 Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation 02/16/2023 INTERVENTIONAL unchanged 1,287.85 0 Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients 02/16/2023 INTERVENTIONAL unchanged 1,287.85 0 Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome 02/17/2023 OBSERVATIONAL unchanged 1,286.85 0 Study on Gynecological Rare Cancers 02/17/2023 OBSERVATIONAL unchanged 1,286.85 0 Avalglucosidase Alfa Pregnancy Study 02/21/2023 OBSERVATIONAL unchanged 1,282.85 0 Stress and Blood Pressure Management for Caregivers 02/21/2023 INTERVENTIONAL unchanged 1,282.85 0 Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer 02/21/2023 INTERVENTIONAL unchanged 1,282.85 0 Molecular Mechanisms Associated With Breast Implant Complications 02/21/2023 OBSERVATIONAL unchanged 1,282.85 0 A Retrospective Assessment of OviTex PRS (OviTex) 02/21/2023 OBSERVATIONAL unchanged 1,282.85 0 Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma 02/21/2023 INTERVENTIONAL unchanged 1,282.85 0 Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer 02/21/2023 INTERVENTIONAL unchanged 1,282.85 0 Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients 02/22/2023 OBSERVATIONAL unchanged 1,281.85 0 Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring 02/22/2023 OBSERVATIONAL unchanged 1,281.85 0 MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy 02/22/2023 OBSERVATIONAL unchanged 1,281.85 0 Sarcopenia and Related Factors in Lipedema 02/22/2023 OBSERVATIONAL unchanged 1,281.85 0 Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer 02/22/2023 INTERVENTIONAL unchanged 1,281.85 0 The Danish TURNER Cryopreservation Study 02/23/2023 INTERVENTIONAL unchanged 1,280.85 0 Gene Editing as a Therapeutic Approach for Rett Syndrome 02/23/2023 OBSERVATIONAL unchanged 1,280.85 0 Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer 02/23/2023 INTERVENTIONAL unchanged 1,280.85 0 Can ILR Reduce the Risk of Arm Lymphedema? 02/24/2023 INTERVENTIONAL unchanged 1,279.85 0 Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) 02/24/2023 INTERVENTIONAL unchanged 1,279.85 0 Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer 02/27/2023 INTERVENTIONAL unchanged 1,276.85 0 At High-risk for Pre-eclampsia After Assisted Reproductive Technology 02/28/2023 OBSERVATIONAL unchanged 1,275.85 0 FUSCC Refractory TNBC Platform Study (FUTURE2.0) 03/01/2023 INTERVENTIONAL unchanged 1,274.85 0 The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer. 03/01/2023 INTERVENTIONAL unchanged 1,274.85 0 Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions 03/01/2023 OBSERVATIONAL unchanged 1,274.85 0 Intravenous Ibuprofen Postoperative Analgesia After Abdominal Hysterectomy 03/01/2023 INTERVENTIONAL unchanged 1,274.85 0 Impact of Serum Progesterone Levels on the Day of β-hCG Test in Artificial Cycles on the Ongoing Pregnancy Rate. 03/02/2023 OBSERVATIONAL unchanged 1,273.85 0 Ultrasound Guided TAPB vs Surgical TAPB With Bupivacaine in Cesarean Section 03/02/2023 INTERVENTIONAL unchanged 1,273.85 0 Effect of Virtual Reality and Music Therapy on Pain Relief in OPH Operations 03/02/2023 INTERVENTIONAL unchanged 1,273.85 0 Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) 03/02/2023 INTERVENTIONAL unchanged 1,273.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology